IMMP1LP3

Across TCGA pan-cancer cohorts, IMMP1LP3 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated IMMP1LP3 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher IMMP1LP3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated IMMP1LP3 expression acts as an unfavorable survival marker, although some lineages such as SARC and HNSC show a favorable association.

MESO, UCS, and LIHC are the cancer types where IMMP1LP3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	II,III,IV	0.162	0.583	.017	45	view →
UCS	DFS	Tertile	II,III,IV	0.144	0.465	.008	36	view →
LIHC	OS	Tertile	III,IV	0.151	0.633	<.001	27	view →
ACC	DFS	Tertile	III,IV	0.050	0.471	.005	27	view →
ESCA	DFS	Quartile	All	0.380	0.895	.016	18	view →
SARC	DFS	Tertile	All	0.695	0.348	.028	18	view →
HNSC	OS	Tertile	All	0.923	0.672	.015	9	view →
LGG	OS	Tertile	All	0.711	0.839	.043	9	view →
SKCM	OS	Tertile	IV	0.140	0.621	.044	6	view →
LUAD	DFS	Quartile	IV	0.404	0.753	.042	6	view →
LUSC	OS	Tertile	All	0.833	0.742	.037	6	view →
THYM	DFS	Tertile	All	0.731	0.943	.028	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

IMMP1LP3–MESO (OS)

Open the MESO breakdown →